A supplement brand wanted to launch an OTC pain reliever without building a packaging line — and found that a contract packager could handle blister packing, labeling, and cartoning at a fraction of the capital cost. Eighteen months later, the product was on shelves, and the brand had avoided millions in equipment investment. At yisenpulp, we believe the highest form of packaging is one you trust before you open it. This guide covers contract packing for OTC drugs in 2026.
What Is Contract Packing for OTC Drugs?
Contract packing is the outsourcing of drug packaging operations to a specialized partner. The packager takes an already-manufactured drug product and handles:
- Filling — into blisters, bottles, or sachets
- Labeling — with Drug Facts panels and compliance information
- Cartoning — into secondary packaging
- Serialization — unique identifiers for DSCSA/EU FMD compliance
It's distinct from contract manufacturing, which covers the full production including formulation.
Table: Contract Packing vs Contract Manufacturing
| Dimension | Contract Packing | Contract Manufacturing |
|---|---|---|
| Scope | Packaging only | Formulation + fill + pack |
| Input | Finished drug | Raw materials |
| Complexity | Lower | Higher |
| Use case | Launch without packaging line | Full outsourcing |
Data: Contract packaging of drug products is governed by cGMP under 21 CFR 210/211 in the United States, which mandates documented quality systems, validated processes, and batch traceability for every packaging operation, per the U.S. FDA.
Insight: Contract packing is not a deregulated shortcut — the packager operates under the same cGMP framework as the brand's own facility, which is why the brand's compliance responsibility transfers to the packager contractually but not legally.
Source: U.S. FDA — "cGMP for Finished Pharmaceuticals — 21 CFR 210/211" (2023)
The cGMP and Serialization Requirements
OTC contract packing carries two compliance burdens that define the selection process.
cGMP. The packager must operate under 21 CFR 210/211 (U.S.) or EU Directive 2001/83/EC, with documented quality systems, validation, and traceability.
Serialization. Under the U.S. DSCSA and EU Falsified Medicines Directive, every saleable unit must carry a unique identifier, and the packager must support aggregation and data reporting.
Table: Contract Packager Compliance Checklist
| Requirement | Standard | Verification |
|---|---|---|
| cGMP | 21 CFR 210/211 / EU 2001/83 | Audit + inspection history |
| Serialization | DSCSA / EU FMD | System capability check |
| Quality system | Documented | SOP review |
| Traceability | Batch records | Audit |
Data: The global pharmaceutical contract packaging market is growing at approximately 7% CAGR, according to Grand View Research, driven by brands outsourcing packaging to access specialized serialization capability and avoid capital expenditure on packaging lines.
Insight: The growth of contract packing reflects a structural shift — serialization has made packaging capital-intensive and technically demanding, pushing brands toward partners who already have the systems, rather than building them in-house.
Source: Grand View Research — "Pharmaceutical Contract Packaging Market Report" (2023)
Choosing a Contract Packager
Five selection criteria:
- cGMP compliance and regulatory history — check FDA 483s and inspection records.
- Serialization capability — DSCSA or EU FMD support is non-negotiable.
- Format fit — blister, bottle, or sachet equipment must match your product.
- Capacity and lead time — ensure the packager can absorb your volume.
- Quality documentation — SOPs, batch records, and change control.
Table: OTC Contract Packing Cost Benchmarks
| Format | Cost per Unit | Notes |
|---|---|---|
| Blister packing | $0.03-0.10 | Most common for tablets |
| Bottling | $0.05-0.15 | Liquids, bulk solids |
| Cartoning | $0.02-0.08 | Secondary packaging |
Data: Serialization requirements under the U.S. DSCSA and EU Falsified Medicines Directive mandate unique identifiers on every saleable drug unit, with aggregation and data reporting — requirements that apply to contract packagers as directly as to brand owners, per the U.S. FDA.
Insight: Serialization has become the defining technical requirement for contract packagers: a packager without DSCSA/FMD serialization capability is effectively excluded from regulated markets, making serialization verification the first gate in selection.
Source: U.S. FDA — "Drug Supply Chain Security Act (DSCSA)" (2023)
The Bottom Line
Contract packing for OTC drugs is a compliance-managed way to launch without building a packaging line — provided you choose a packager who can prove cGMP compliance, serialization capability, and format fit.
The highest form of packaging is one you trust before you open it — and in contract packing, that trust is earned through audits, certificates, and inspection history, not marketing claims. Verify first, then outsource.